Multaq® (dronedarone) Dosage
The only recommended dosage for Multaq® is 400 mg, one in the morning and one in the evening. The medication comes as white film-coated tablets. They are oblong-shaped and engraved with a double wave marking on one side and "4142" code on the other.
Multaq®'s Medication Guide tells patients not to double up on doses. If a dose is missed, the patient should take the next dose at the regularly scheduled time. Multaq® should be taken with food.
Important Multaq® Patient Information
It is important for patients to understand that Multaq® should not be taken by anyone with severe heart failure. Heart failure is indicated by any physical activity causing shortness of breath, or shortness of breath while resting or after only a small amount of exercise. Patients should not take Multaq® if they were hospitalized within the last month for heart failure, even if they are now better.
Information doctors should tell their patients include:
- Take Multaq® with a meal
- Do not take Multaq® with grapefruit juice
- Do not take a double dose if a pill is missed
Patients should call their doctor if they develop signs or symptoms of worsening heart failure such as:
- Rapid weight gain of more than five pounds
- Swelling in the legs or feet
- Increasing shortness of breath
- Problems sleeping or waking at night due to problems breathing
- Needing more pillows to prop yourself up to breathe more easily
- Wheezing, chest tightness, or coughing up frothy sputum at rest, nighttime, or after minor exercise
Patients should also call their doctor if they experience symptoms of liver problems, such as:
- Yellowing of the eyes and/or skin
- Dark-colored urine
- Light-colored stools
- Nausea or vomiting
Tell your doctor if you have a history of:
- Heart failure
- Heart rhythm disturbance other than atrial fibrillation or flutter
- A history of lower-than-normal potassium levels in the blood (hypokalemia)
Let your doctor know what other prescription or nonprescription medications or herbal products (particularly St. John's wort) you are taking, as some medications can interact negatively with Multaq®.
Patients also should be aware of the serious side effects that Multaq® presents. A recent study found that Multaq® should not be taken by patients with permanent atrial fibrillation (as opposed to paroxysmal or persistent atrial fibrillation).
The study showed that patients with permanent atrial fibrillation had twice the risk as control patients taking a placebo of:
If you took Multaq® and have suffered new or worsened heart failure, or liver failure, you might be eligible for compensation. To learn more, please contact our Multaq® injury lawyers for help today.